US Patent 7485642 Method for treating septic shock
Patent 7485642 was granted and assigned to Orion Corporation on February, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+239 characters)
Article
Patent abstract
Levosimendan, or (−)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile, which has been mentioned for the treatment of congestive heart failure, is useful in the treatment of septic shock.
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07485642 Method for treating septic shock US Patent 7485642 Method for treating septic shock
Infobox
Patent Number
0748564200
Patent Number
748564200
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074856420
Date of Patent
February 3, 2009
0Patent Application Number
103124500
Date Filed
June 28, 2001
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074856420
Date of Patent
February 3, 2009
0Patent Application Number
103124500
Date Filed
June 28, 2001
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07485642 Method for treating septic shock
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07485642
Date of patent
February 3, 2009
Patent application number
10312450
Date Filed
June 28, 2001
Patent primary examiner
Find more entities like US Patent 7485642 Method for treating septic shock
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
